Clinical Trial Update: Dose Escalation With Remicade® and Orencia®

View source ↗

Summary

Clinical trial update reporting completion of a dose-escalation study combining Remicade and Orencia for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ORENCIA (ABATACEPT)
• Remicade (infliximab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Status: COMPLETED